HTF Pharma has a UK WDA(H) to procure, import (from countries on the approved list) and supply the UK market. The primary product portfolio being that of low volume, high value, with hospital and/ or pharmacy distribution channels. This can include Orphan Drugs.

In addition to licensed products, HTF Pharma can support UK market distribution for unlicensed products during the crucial period where the marketing authorisation or reimbursement and commercialisation is in progress.

HTF Pharma is independently operated, with decades of combined industry experience, our team understands the critical importance of integrity, compliance, and efficiency in the pharmaceutical supply chain.

HTF Pharma’s services enable clients, specifically the MAH or their Nominated Distributor, to rapidly build a platform to distribute products within the UK without the need to initially:
- obtain their own UK WDA(H)/ Controlled Drugs licence
- recruit teams and expertise to serve the UK market
- establish systems and process, including a GDP-compliant QMS
Clients can readily add new products to the HTF Pharma platform, as required, reducing time and investment for UK market access. 

HTF Pharma is a fully owned subsidiary of HTF Associates and is consequently well positioned to successfully support Client portfolio growth should it become viable for Clients to hold their own WDA(H) in the future.

HTF Pharma Limited

Org chart

Teams

Offices